Renalytix announced the execution of a Co-operative Research and Development Agreement with the U.S. Veterans Health Administration Innovation Ecosystem to install the KidneyIntelX solution inside the VA Health System’s Cloud Infrastructure and interface it with the VA Electronic Health Record Systems. This marks a significant milestone in enabling providers at 171 VA Medical Centers and related outpatient clinics to order and receive test results in a seamless manner. The program will commence immediately and will be implemented on a phased basis over an approximate 18-month period.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on RNLX:
- Renalytix price target lowered to $8 from $10 at H.C. Wainwright
- Renalytix announces highlights from publication of data on use of KidneyIntelX
- Renalytix reports Q1 EPS (16c), consensus (13c)
- Renalytix Reports Financial Results for First Quarter of Fiscal Year 2023
- Renalytix announces publication highlighting KidneyIntelX test